BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

New Hartley Analyst report on Bot, page-36

  1. 1,037 Posts.
    lightbulb Created with Sketch. 439
    Due to the nature of the issue the FDA may agree to speed up the process, or surprise us. I guess we’ll see at our next meeting. We might end up with only a 4 or 5 month delay. Wishful thinking but possible and reasonable.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.